To use this site, please disable the ad blocking feature and reload the page.
This website uses cookies to collect information about your visit for purposes such as showing you personalized ads and content, and analyzing our website traffic. By clicking “Accept all,” you will allow the use of these cookies.
Users accessing this site from EEA countries and UK are unable to view this site without your consent. We apologize for any inconvenience caused.
Reuters file photo Logos of Takeda Pharmaceutical Co are seen at an office building in Glattbrugg near Zurich March 7, 2012.
Reuters
15:24 JST, May 11, 2023
Operating profit for the year ended March 31 came in at 490.5 billion yen ($3.63 billion) compared with 461 billion yen in the year prior, the company said.
That compares with the drugmaker’s earlier estimate of 530 billion yen and a consensus forecast of 535 billion yen from a Refinitiv poll of 15 analysts.
The company, meanwhile, estimated the current fiscal year’s operating profit to touch 349 billion yen.
